Author:
Smith John D.,Rose Marlene L.
Publisher
Springer International Publishing
Reference51 articles.
1. Aubert V, Venetz JP, Pantaleo G, Pascual M. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant. Hum Immunol. 2009;70:580–3.
2. Bang H, Egerer K, Gauliard A, Luthke K, Rudolph PE, Fredenhagen G, Berg W, Feist E, Burmester GR. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum. 2007;56:2503–11.
3. Besarani D, Cerundolo L, Smith JD, Procter J, Barnardo MC, Roberts IS, Friend PJ, Rose ML, Fuggle SV. Role of anti-vimentin antibodies in renal transplantation. Transplantation. 2014;98:72–8.
4. Bierl C, Miller B, Prak EL, Gasiewski A, Kearns J, Tsai D, Jessup M, Kamoun M. Antibody-mediated rejection in heart transplant recipients: potential efficacy of B-cell depletion and antibody removal. Clin Transpl. 2006;2006:489–96.
5. Brugiere O, Suberbielle C, Thabut G, Lhuillier E, Dauriat G, Metivier AC, Gautreau C, Charron D, Mal H, Parquin F, Stern M. Lung transplantation in patients with pretransplantation donor-specific antibodies detected by luminex assay. Transplantation. 2013;95(5):761–5.